E
Solaris Resources Inc. SLS.TO
TSX
Recommendation
Sell
Prev Close
$4.73
Volume
--
Avg Vol (90D)
297,834
Market Cap
$534.05M
Dividend & Yield
--
52-Week Range
$2.58 - $5.90
P/E (TTM)
--
EPS (TTM)
-$0.395
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D-
Weak
Rating Factors
Growth Index
Very Weak
Efficiency Index
Very Weak
Solvency Index
Good
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) Sees Large Decrease in Short Interest
3/7/2025 - MarketBeat
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) Short Interest Down 11.8% in February
3/7/2025 - Ticker Report
Oncology Breakthroughs: How Cancer Research Is Advancing in 2025
2/27/2025 - CNW Group - News Releases
Oncology Breakthroughs: How Cancer Research Is Advancing in 2025
2/27/2025 - PR Newswire
SELLAS Life Sciences Group reports positive results from mid-stage lymphoma treatment trial
2/20/2025 - Seeking Alpha - Healthcare
Sellas Life Sciences' zanubrutinib combination shows efficacy in DLBCL
2/20/2025 - TipRanks Financial Blog
Sellas Life Sciences' zanubrutinib combination shows efficacy in DLBCL
2/20/2025 - The Fly
SELLAS Announces Positive Data from Phase 2a Trial of SLS009 in Combination with Zanubrutinib in DLBCL
2/20/2025 - Globe Newswire
SELLAS Life Sciences Group Target of Unusually High Options Trading (NASDAQ:SLS)
2/5/2025 - Ticker Report
Investors Buy High Volume of Call Options on SELLAS Life Sciences Group (NASDAQ:SLS)
2/4/2025 - MarketBeat
SELLAS Life Sciences Group Sees Unusually High Options Volume (NASDAQ:SLS)
2/3/2025 - MarketBeat
SELLAS Life Sciences Group Announces $25 Million Registered Direct Offering Priced ...
1/28/2025 - GuruFocus
SELLAS Life Sciences Group Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
1/28/2025 - Globe Newswire
Traders Buy High Volume of SELLAS Life Sciences Group Put Options (NASDAQ:SLS)
1/25/2025 - Ticker Report
SELLAS Life Sciences Group Sees Unusually High Options Volume (NASDAQ:SLS)
1/24/2025 - MarketBeat
SELLAS Life Sciences Announces Positive Phase 3 Trial Results
1/23/2025 - TipRanks Financial Blog
SELLAS Life Sciences falls after data for blood cancer therapy
1/23/2025 - Seeking Alpha - Healthcare
SELLAS Life Sciences Announces Positive Outcome of Interim Analysis for its Pivotal Phase 3 ...
1/23/2025 - GuruFocus
Sellas Life Sciences announces IDMC completed interim analysis of REGAL trial
1/23/2025 - The Fly
SELLAS Life Sciences Announces Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of GPS in Acute Myeloid Leukemia
1/23/2025 - Globe Newswire
SELLAS Life Sciences Group Sees Unusually High Options Volume (NASDAQ:SLS)
1/18/2025 - MarketBeat
SELLAS Life Sciences Group Target of Unusually High Options Trading (NASDAQ:SLS)
1/18/2025 - Ticker Report
SELLAS Life Sciences Amends Severance for Key Executives
1/16/2025 - TipRanks Financial Blog
Geode Capital Management LLC Purchases 88,183 Shares of SELLAS Life Sciences Group, Inc. (NASDAQ:SLS)
1/11/2025 - Ticker Report
Sellas Life Sciences announces key business objecives for 2025
1/8/2025 - The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$58.53M
EBIT (TTM)
-$59.57M
Net Income (TTM)
-$61.19M
Balance Sheet
Total Assets (Q)
$77.59M
Total Debt (Q)
$48.11M
Total Liabilities (Q)
$62.98M
Book Value Per Share (Q)
$0.0416
Cash Flow
Cash from Operations (TTM)
-$46.01M
Cash from Investing (TTM)
-$1.60M
Cash from Financing (TTM)
$92.90M
Net Change in Cash (TTM)
$45.78M
Filings
Filing Date
Tuesday, November 12, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 24 and 28 (est)
Price History
Loading...
Beta
1.11
7-Day Total Return
-0.87%
30-Day Total Return
-7.49%
60-Day Total Return
-3.59%
90-Day Total Return
45.08%
Year to Date Total Return
-1.30%
1-Year Total Return
10.65%
2-Year Total Return
-16.91%
3-Year Total Return
-65.92%
5-Year Total Return
--
52-week Low
Sep 06, 2024 - $2.58
52-week High
Feb 14, 2025 - $5.90
Valuation
Market Cap
$534.05M - Small Cap
Enterprise Value
$537.30M
Price/Sales (TTM)
--
Price/Book (Q)
113.70
Dividends and Shares
Shares Outstanding
162.31M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.solarisresources.com
Phone Number
604 687 1717
Address
999 Canada Place
Vancouver, BC V6C 3E1
Country
Canada
Year Founded
2018
Business Description
Sector
Materials
Industry
Materials
Solaris Resources Inc. engages in exploration of mineral properties. It focuses on exploring copper, molybdenum, gold, lead, zinc, and silver. The company’s flagship project is the 100% owned... more
Weiss Ratings